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Enterococcus lactis IW5 was obtained from human gut and the potential probiotic
characteristics of this organism were then evaluated. Results showed that this strain
was highly resistant to low pH and high bile salt and adhered strongly to Caco-
2 human epithelial colorectal cell lines. The supernatant of E. lactis IW5 strongly
inhibited the growth of several pathogenic bacteria and decreased the viability of
different cancer cells, such as HeLa, MCF-7, AGS, HT-29, and Caco-2. Conversely,
E. lactis IW5 did not inhibit the viability of normal FHs-74 cells. This strain did
not generate toxic enzymes, including β-glucosidase, β-glucuronidase, and N-acetyl-
β-glucosaminidase and was highly susceptible to ampicillin, gentamycin, penicillin,
vancomycin, clindamycin, sulfamethoxazol, and chloramphenicol but resistant to
erythromycin and tetracyclin. This study provided evidence for the effect of E. lactis
IW5 on cancer cells. Therefore, E. lactis IW5, as a bioactive therapeutics, should be
subjected to other relevant tests to verify the therapeutic suitability of this strain for
clinical applications.
Keywords: anticancer, enzyme activity, antibiotic susceptibility, apoptosis, cytotoxicity
INTRODUCTION
Probiotics are non-pathogenic live microorganisms that provide health beneﬁts when these
organisms are consumed in suﬃcient amounts (FAO/WHO, 2001; Mehra et al., 2012; Howarth and
Wang, 2013; Haghshenas et al., 2014a; Nami et al., 2014a). Probiotics have been utilized to prevent
bacterial infections (Forsyth et al., 2009) and treat cancer (Baldwin et al., 2010; Haghshenas et al.,
2014b, 2015a,b; Nami et al., 2014b,c,d). These organisms can also create an acidic environment
in the colon by producing short-chain fatty acids. Furthermore, probiotic bacteria can inhibit
the occurrence of cancer by (i) lowering pH, (ii) reducing the level of pro-carcinogenic enzymes
(Donaldson, 2004), (iii) enhancing cell proliferation by inhibiting normal cell apoptosis and by
promoting cell diﬀerentiation and cytoprotective activities (Lin et al., 2008), and (iv) suppressing
inﬂammation-induced cell apoptosis (Prisciandaro et al., 2011) caused by lactic acid bacteria
(LAB), including Lactobacillus, Enterococcus, Streptococcus, and Bifidobacterium. Among these
LABs, the genus Enterococcus has gained considerable interest in environmental, food, and clinical
research (Sharma et al., 2012).
Enterococcus is ubiquitous in nature and considered as the most controversial LAB genus
because of unclear functions (Galvez et al., 2009). Enterococci have been utilized as adjutants
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to treat human and animal diseases. Enterococci have also been
used in the food industry as probiotics (Franz et al., 2003) or
as starter cultures because these microorganisms produce useful
bacteriocins (Fisher and Phillips, 2009). Although Enterococcus
comprises many species, only a few species are recognized as
probiotics, such as E. faecalis, E. faecium, and E. lactis. Probiotics
should exhibit important characteristics, such as tolerant to
gastrointestinal conditions (acid and bile) and non-pathogenic;
probiotics should also display competitive exclusion of pathogens
(Collins et al., 1998; Ouwehand et al., 2002). Thus, the selection
criteria of probiotic bacteria for clinical applications should be
carefully evaluated. This study aimed to determine the probiotic
properties (bile tolerance, antimicrobial activity, and antibiotic
susceptibility) and antitumor activities of E. lactis isolated from
the human gut.
MATERIALS AND METHODS
Bacterial Strain and Culture Condition
Enterococcus lactis IW5 was isolated from human fecal samples
using streak plate method previously described by Shin et al.
(2015) and this strain was maintained at −70◦C in de Man
Rogosa broth (MRS, Merck, Germany) containing 25% (v/v)
glycerol. E. lactis IITRHR1 isolated from cheese was used as a
control strain. Working cultures were anaerobically incubated
at 37◦C for 24 h in an anaerobic jar (Mitsubishi Inc. USA) that
contains anaerobic gas generation kits (AnaeroPack).
Tolerance to Artificial Gastric Juice and
Artificial Bile Acid
Tolerance to artiﬁcial gastric juice and bile acid were
determined according to previously described method with
slight modiﬁcation (Lee et al., 2014). E. lactis was suspended in
MRS containing 0.1% pepsin (Sigma, St. Louis, MO, USA) and
adjusted to a pH of 2.0 with 0.1 M HCl, and then incubated
for 3 h at 37◦C. Artiﬁcial bile acid tolerance was measured by
cultivating cells treated with artiﬁcial gastric juice. The cells were
incubated at 37◦C for 24 h in artiﬁcial bile acid consisting of
MRS containing 0.3% oxgall (Becton Dickinson, Sparks, MD,
USA). The numbers of viable cells were measured by incubating
aliquots for 24 h on MRS agar plates at 37◦C. The survival rate
was calculated using the formulation:
Survival rate (%) = (Log CFU after reaction/Log CFU at
0 h) × 100
Antimicrobial Susceptibility Assay
Thirteen pathogenic organisms from the Persian Type Culture
Collection (Table 1) were selected to detect antagonistic
substances. Well diﬀusion was performed to detect inhibitory
substances produced in the supernatant ﬂuid of the isolate. For
this purpose, an overnight culture of the indicator strains was
used to inoculate appropriate agar growth media (Dimitonova
et al., 2007) at 37◦C. Wells with a diameter of 5 mm were cut
into agar plates; afterward, 50 μL of ﬁltered cell-free supernatant
obtained from the third subculture of the microorganisms grown
in MRS broth (cell density 108 cfu/mL) was added to each well.
The supernatant was obtained by growing inhibitory producer
strains overnight in MRS broth at 37◦C. The cells were removed
through centrifugation; the supernatant was placed in the wells
and allowed to diﬀuse in agar for 2 h at room temperature. The
plates were incubated at optimum growth temperature of the
indicator strains and examined after 24 h to determine inhibition
zone areola diameter (Nowroozi et al., 2004; Maldonado et al.,
2012).
Enzyme Activity
Enzyme activity was evaluated using an API ZYM kit
(BioMerieux, Paris, France). E. lactis IW5 was suspended in
sterile saline (0.85% NaCl) at 105 CFU/mL and added to each
cupule. After inoculation was performed, the cultures were
incubated at 37◦C for 4 h. One drop of ZYM B reagent was
added and a drop of surface-active agent (ZYM reagent) was
added to each cupule. ZYM A was introduced to facilitate ZYM
B solubilization in the medium. The resulting color was observed
for at least 5 min. Values ranging from 0 to 5 were assigned on
the basis of color strength to determine the approximate amount
(in nmol) of hydrolyzed substrate.
Cell Cultures
Five human cancer lines, namely, Caco-2 (human colorectal
carcinoma cell), AGS (human gastric carcinoma cell), MCF-7
(human breast carcinoma cell), HeLa (human cervical carcinoma
cell), and HT-29 (human colon carcinoma cell), and one
normal cell line, namely, FHs-74 (human intestinal epithelial
cells) – obtained from cell resource center of Pasteur institute
of Iran (Tehran, Iran) – were used to investigate the anticancer
eﬀects of E. lactis IW5. The cells were grown in RPMI-
1640 medium supplemented with 10% heat-inactivated fetal
bovine serum and a 1% penicillin–streptomycin mixture. The
cultures were maintained at 37 ◦C in an atmosphere of 95%
O2 and 5% CO2 with relative humidity (Merghoub et al.,
2009).
Cell-free Culture Supernatant
Preparation
The liquid culture of E. lactis at the end of the exponential growth
phase was centrifuged at 4000 × g for 10 min to obtain cell
precipitates. The supernatant was collected; pH was adjusted to
7.2 with 1 N NaOH and subjected to lyophilization. Endogenous
proteases were inactivated by heat at 100 C for 3–5 min. The
desired concentrations of lyophilized culture supernatant (10–
50 μg/mL) were prepared in RPMI media by diluting from stock
solution (10 mg lyophilized supernatant/mL RPMI media) and
sterilized by ﬁltering the supernatant through a 0.22μm bacterial
ﬁlter (Millipore); the prepared supernatant was then used to treat
cancer cells.
Adhesion to Caco-2 Cells
Enterococcus lactis IW5 was assessed for its adhesion ability to the
human colon carcinoma cell line, Caco-2. The cells were seeded
in RPMI-1640 medium supplemented with 10% heat-inactivated
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TABLE 1 | The inhibitory effect of Enterococcus lactis IW5 against pathogenic bacteria.
Test organisms Growth conditions Origin Susceptibility
Salmonella typhimurium
Escherichia coli O26
E. coli O157
Staphylococcus aureus
Bacillus cereus
Listeria monocytogenes
Klebsiella pneumoniae
Shigella flexneri
Pseudomonas aeroginosa
Candida albicans
Serratia marcesens
Streptococcus mutans
Staphylococcus
saprophyticus
MPA, 37◦C
LB, 37◦C
LB, 37◦C
Blood agar, 37◦C
MPA, 37◦C
BHI, 37◦C
MPA, 37◦C
MHA, 37◦C
MPA, 37◦C
MHA, 28◦C
MHA, 37◦C
MHA, 37◦C
Blood agar, 37◦C
ATCC 14028
Native strain
PTCC 1276
ATCC 25923
PTCC 1539 (ATCC 11778)
PTCC 1163
PTCC 1053 (ATCC 10031)
PTCC 1234 (NCTC 8516)
PTCC 1181
PTCC 5027 (ATCC 10231)
PTCC 1187 (Native strain)
PTCC 1683 (ATCC 35668)
PTCC 1440 (CIP 76.125)
R
S
R
S
S
ES
S
S
R
R
R
SS
R
R: 0 mm; SR: 0–4 mm; SS: 4–8 mm; S: 8–12 mm; ES: >12 mm.
CIP, Collection of Bacteries de l’Institute Pasteur, Paris, France; ATCC, American Type Culture Collection, Virginia, USA; NCTC, National Collection of Type Cultures,
London, UK; PTCC, Persian Type Culture Collection, Tehran, Iran.
MPA, mycophonolic acid; LB, Lysogeny broth; BHI, Brain-heart infusion medium; MHA, Mueller Hinton Agar.
fetal bovine serum and 1% penicillin/streptomycin mixture. Cells
were seeded on 24-well tissue culture plates and incubated at
37◦C in 5% CO2 in a relatively humid atmosphere until a
conﬂuent monolayer was achieved. Adherence assay was carried
out by adding 1 mL of the bacterial strain, suspended in RPMI-
1640 medium, at a concentration of about 1 × 107 CFU/well
and was incubated for 3 h at 37◦C in an atmosphere of 5% (v/v)
CO2. Before the adhesion assay, the media in the wells containing
a Caco-2 cell monolayer were removed and replaced once with
fresh antibiotic-free RPMI.
To remove non-attached bacterial cells, the wells were washed
three times with a sterile, pre-warmed PBS solution. To detach
the cells from the wells, 1 mL of trypsin/EDTA solution (0.5%
porcine trypsin and 0.2% EDTA in PBS; Sigma) was added to each
well and the mixture was gently stirred for 5 min. To measure
the viable Caco-2 cell count, the cells were counted by the pure
plate method onto MRS agar medium and incubated at 37◦C
under anaerobic conditions. Bacterial adhesion was expressed as
the total number of bacteria attached to viable Caco-2 cells.
Cytotoxicity against Different Cancer
Cells
The cytotoxicity of the isolated E. lactis on tumor/normal cells
was evaluated through a microculture tetrazolium [MTT, 3-(4,
5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay
(Mosmann, 1983). In brief, HeLa, AGS, MCF-7, HT-29, Caco-
2, and FHs 74 cells (1.2 × 104 cells/well) were seeded in each
well of a 96-well microplate with RPMI growth medium. Once
50% conﬂuence was reached 24 h after the cells were seeded, the
cells were treated with the ﬁltered supernatant of the isolated
strain at diﬀerent time points (12, 24, and 48 h). After treatment
was administered, the medium was replaced with 200 μl of
fresh medium containing 50 μl of MTT solution (2 mg/mL in
PBS) and incubated for another 4 h at 37 C. After incubation
was completed, the MTT mixture was carefully removed, and
200 μl of dimethyl sulfoxide and 25 μl of Sorenson’s glycine
buﬀer (0.1 M glycine and 0.1 M NaCl at pH 10.5) were added
to each well and incubated for 30 min. The absorbance of each
well was determined after 30 s of shaking by using a microplate
reader (Biotek, ELx 800, USA) at 570 nm. The cells treated
with MRS (bacterial culture medium) and Taxol (anticancer
drug as a reference) served as negative and positive controls,
respectively.
Apoptotic Cells Detection
4′,6-diamidino-2-phenylindole (DAPI) staining
All of the cultured cells (treated/untreated groups) were evaluated
through 4′,6-diamidino-2-phenylindole (DAPI) staining to
detect apoptotic cells. For this purpose, sterile cover slips were
placed in each of the six wells of the culture plate. Cancer cells
(120 × 104 cells/well) were added to each well and maintained
under the desired standard culture condition. At 24 h after the
cells were seeded, all of the cultured cells were subjected to
E. lactis secretion, MRS medium, and Taxol (IC50 concentration)
treatments. The treated and untreated control groups were
incubated for another 24 h and prepared for apoptosis assay.
Afterward, 4% paraformaldehyde was added to each well to stain
cells with DAPI dye. The cells were ﬁxed and permeabilized
with 0.1% Triton-X100 for 5 min. The permeabilized cells were
stained with 50 μl of DAPI dye (1:2000 dilutions) and incubated
for 3 min at room temperature. The processed cells with cover
slips were washed thrice with PBS (pH 7.2) and utilized to assess
apoptosis by using a ﬂuorescent microscope (BX64, Olympus,
Japan) equipped with a U-MWU2 ﬂuorescence ﬁlter (excitation
ﬁlter BP 330-385, dichromatic mirror DM 400, and emission ﬁlter
LP 420; Paolillo et al., 2009).
Flow cytometry
The fraction of apoptotic cells was quantitatively measured
via ﬂow cytometry using the Annexin V-FITC apoptosis
detection kit (eBioscience, San Diego, CA, USA). HeLa cell line
(1.2 × 105 cells/well) was seeded into a six-well culture plate
and the treatment of cells were similar to DAPI staining. After
treatment time point (24 h), the treated/untreated control cells
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were detached by trypsin, the supernatant was discarded after
centrifugation at 900 rpm for 10 min at 28 C, and the cell
pellet was resuspended in 500 μl of 1× binding buﬀer and
transferred into a new 5 ml tube. The tubes were centrifuged
again and the supernatants were replaced with100 μl binding
buﬀer (1×). Afterward, the tubes were added with 5 μl of FITC-
conjugated Annexin V then were incubated for 15 min at room
temperature under dark conditions. The incubated cells were
centrifuged and the cell plates were resuspended in 500 μl of
binding buﬀer (1×). Finally, 5 μl of propidium iodide solution
was added to the cells, and quadrant settings were ﬁxed with
untreated, single-stained controls, and copied to dot plots of
the treated cells. Quadrant statistic calculations were performed
using CELLQuest Pro software (BD Biosciences, San Jose, CA,
USA). The experiment was repeated two times with triplicate
samples for each experiment. Analyses were accomplished using
10000 cells at a rate of 450 cells/s.
Quantitative Real Time PCR
For RNA analysis, HeLa cells were lysed using TRI
Reagent R©(Sigma Chemical Co., Poole, UK) according to
manufacture guidelines. 24 h post-treatment or untreated
control monolayer cells were lysed by adding desired amount
of TRI Reagent R© (2 mL per 25 cm2 T-ﬂask) accordingly were
homogenized and transferred to RNAse/DNAse-free microtubes.
Chloroform (0.2 mL per each mL of TRI ReagentTM used for
lysing) was added to each sample, and the mixture was vortexed.
After maintaining at room temperature for 5 min, the samples
were centrifuged at 12000 × g, 4◦C and 10 min and the colorless
supper aqueous phase was carefully separated and mixed with
ice-cold isopropanol (0.5 mL per each mL of TRI Reagent R© used
initially). The mixture was centrifuged at12000 × g, 4◦C for
10 min, yielding total RNA pellet that was washed with 75%
ethanol (×3). The air dried samples were dissolved in DEPC
treated water and tested qualitatively and quantitatively prior to
its use for RT-PCR experiments.
The isolated RNA was reverse transcribed to cDNA using
Moloney- murine leukemia virus (MMLV) reverse transcriptase
(Bethesda Research Laboratories, Gaithersburg, MD, USA). For
RT reaction, 1 μL RNA (1 μg/μL) was mixed with master mix
[DEPC treated water 13μL, dNTP’s (10μM) 2μL, MMLV buﬀer
with DTT 2 μL, random hexamer primer (pdN6; 400 ng/μL)
0.5 μL], and denatured at 95◦C for 5 min. The sample was
then cooled down to 4◦C for 5 min using ice-bath. Then 1 μL
MMLV (200 U/μL) and 0.5 μL RNase in (40 U/μL) were added
to the sample and the mixture was incubated using following
thermocycling program: 10 min at 25◦C, 42 min at 42◦C, and
5 min at 95◦C. The prepared cDNA templates were used for real
time PCR experiments.
Primers were designed from published Gene Bank sequences
using Beacon Designer 5.01 (Premier Biosoft International,
http://www.premierbiosoft.com) and listed in Table 3. All
ampliﬁcation reactions were performed in a total volume of 25μL
using iQ5 Optical System (Bio-Rad Laboratories Inc., Hercules,
CA, USA). Each well contained: 1 μL cDNA, 1 μL primer
(100 nM each primer), 12.5 μL 2× Power SYBR Green PCR
Master Mix (Applied Biosystems, Foster City, CA, USA), and
10.5 μL RNAse/DNAse free water. Thermal cycling conditions
were as follow: 1 cycle at 94◦C for 10 min, 40 cycles at 95◦C for
15 s, 56–62◦C (annealing temperature) for 30 s, and 72◦C for
25 s. Interpretation of the result was performed using the Pfaﬄe
method and the threshold cycle (Ct) values were normalized
to the expression rate of GAPDH as a housekeeping gene. All
reactions were performed in triplicate and negative controls were
included in each experiment.
Statistical Analysis
Data were analyzed by one-way ANOVA. Signiﬁcant diﬀerences
of means (p < 0.05) were compared through Duncan’s test by
using SPSS 19.0. Graphs were prepared using Microsoft Oﬃce
Excel (Rahmati, 2011).
RESULTS AND DISCUSSION
Isolation and Identification
The bacterial strain was isolated from the human gut. The strain
was initially identiﬁed by phenotypic methods; the Gram reaction
of the isolates was determined by observation under a light
microscope after Gram staining by using a Gram staining kit.
LAB were considered Gram positive when they appeared blue–
purple upon Gram staining. The isolates did not produce gas
bubbles when hydrogen peroxide solution (3%) drops (Sigma–
Aldrich, USA) were added to bacterial cells to determine catalase
positive/negative strains; hence, the result conﬁrmed that this
strain is a Gram-positive and catalase-negative bacterium. A total
of 45 Gram-positive and catalase-negative strains were obtained.
Based on 16S rRNA identiﬁcation results, the 45 isolated bacteria
were classiﬁed into three major groups of LAB: enterococci,
lactobacilli, and lactococci. After sequencing was performed, the
strains belonging to Enterococcus genus were categorized into
nine diﬀerent species: one E. lactis, two E. pseudoavium, four
E. hirae, two E. gilvus, four E. avium, three E. durans, eight
E. faecalis, ﬁve E. malodoratus, and seven E. faecium. Moreover,
lactobacilli were classiﬁed into three diverse species: one L. casei,
three L. acidophilus, and one L. plantarum. Lactococci were
classiﬁed into one species: three Lactococcus lactis, with two
subspecies, namely, L. lactis ssp. lactis and L. lactis ssp. cremoris.
Probiotics have been extensively investigated because these
organisms provide health beneﬁts when such probiotics are
consumed in suﬃcient amounts. In this study, LAB species with
probiotic and antitumor activities were isolated; the strains that
could grow in 5% CO2 atmosphere. An E. lactis strain (Accession
number: HF562969.1) resistant to pH 2.0 and 0.3% bile salt was
isolated from the human gut and then identiﬁed.
Acid and Bile Tolerance
The survival of E. lactis IW5 and E. lactis IITRHR1 in artiﬁcial
gastric juice (pH 2.0,0.1% pepsin, for 3 h) and artiﬁcial bile
salt (0.3% oxgall, for 24 h)was evaluated (Table 1). The cells of
E. lactis IW5 and E. lactis IITRHR1 were strongly maintained,
with 94.60 and 92.27% survival rate in artiﬁcial gastric juice,
respectively. In artiﬁcial bile salt, the cells of E. lactis IW5 and
E. lactis IITRHR1demonstrated 95.46 and 94.14% survival rate,
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respectively. Our ﬁndings are similar to those of previous studies,
which revealed that the survival rates of Enterococcus bacteria
treated with acid and bile range from 63 to 100% (Haghshenas
et al., 2014b; Nami et al., 2014d). Similarly, it has been revealed
that Enterococcus bacteria were very stable in acidic conditions
(pH 2 for 3 h) and high bile salt (0.3% oxgall for 4 h; Bhardwaj
et al., 2010).
Antimicrobial Susceptibility Assay
The antimicrobial susceptibility spectrum of E. lactis IW5 is
shown in Table 2. This strain inhibited the growth of pathogenic
bacteria, including Escherichia coli O26, Staphylococcus aureus,
Bacillus cereus, Klebsiella pneumoniae, Shigella flexneri, and
Streptococcus mutans. Moreover, E. lactis exhibited strong activity
against Listeria monocytogenes. No signiﬁcant activity was
observed against Serratia marcesens, Pseudomonas aeruginosa,
Candida albicans, Staphylococcus saprophyticus, Escherichia coli
O157, and Salmonella typhimurium.
The 50% inhibitory concentration (IC50) of isolated strain
metabolites was determined as an index of antagonistic activity
from the antimicrobial time and dose-dependent curves. After
24 h of incubation, IC50 values were only observed in E. coliO26,
S. aureus, B. cereus, K. pneumoniae, S. flexneri, S. mutans, and
L. monocytogenes cells treated with E. lactis secretions. The IC50
for E. lactis secretions on E. coli O26, S. aureus, and B. cereus
cells was 47, 28 and 32 μg/mL, respectively. The IC50 values of
E. lactis secretions on K. pneumoniae, S. flexneri, and S. mutans
cells was 31, 26 and 22 μg/mL, respectively. The IC50 value of
E. lactis secretions on L. monocytogenes cells showed the lowest
value (13 μg/mL). Our results showed that the E. lactis IW5
strain obtained from the human gut exhibited good probiotic
properties, such as low pH and bile salt resistance. This strain was
capable to inhibit several pathogenic bacteria.
Enzyme Activity
Certain enzymes are characteristically produced by probiotics
to provide protection from toxic substances. β-glucosidase,
N-acetyl-β-glucosaminidas, and β-glucuronidase have been
associated with certain health disorders (Chen et al., 2014).
β-glucuronidase increases the risk of carcinogenesis by secreting
toxins and mutagens (Delgado et al., 2007; Dabek et al., 2008).
These toxic enzymes could be produced by microorganisms.
TABLE 2 | Tolerance of E. lactis IW5 and E. lactis IITRHR1 against artificial
gastric and bile conditions.
Treatment Log CFU/mL
E. lactis IW5
Initial cell no.
pH 2.0, 0.1% pepsin, 2 h
0.3% oxgall, 24 h
8.15 ± 0.26
7.71 ± 0.12
7.78 ± 0.36
E. lactis IITRHR1
Initial cell no.
pH 2.0, 0.1% pepsin, 2 h
0.3% oxgall, 24 h
8.36 ± 0.18
7.71 ± 0.21
7.87 ± 0.19
The results are represented as mean ± SD.
Our data demonstrated that E. lactis did not produce toxic
enzymes, including β-glucosidase, N-acetyl-β-glucosaminidase,
and β-glucuronidase. Conversely, E. lactis produced various
enzymes, including esterase (20 nmol), acid and alkaline
phosphatase (5 nmol), and esterase lipase (≥25 nmol).
Adhesion Ability to Colon Endothelial
Cells
Several investigations have implicated a number of factors in
the attachment of probiotic bacterial cells to epithelial cells.
Such factors include: passive entrapment of the bacterial cells
by ﬁmbrial cell matrix material (Sarem et al., 1996), bacterial
cell surface-associated lipoteichoic acid (Granato et al., 1999),
proteinaceous extracellular adhesins (Conway and Kjelleberg,
1989), and bacterial cell surface-associated proteinaceous factors
(Adlerberth et al., 1996). Adhesion of E. lactis IW5 and E. lactis
IITRHR1 was conﬁrmed by using the plating technique. When
E. lactis IW5 was plated at a concentration of 8.35 ± 0.06 log
CFU/well, we found that 8.16± 0.04 log CFU/well of the bacteria
adhered to the Caco-2 cells. Conversely, when E. lactis IITRHR1
was plated at a concentration of 8.13 ± 0.05 log CFU/well, it was
found that only 6.45 ± 0.03 log CFU/well of the bacteria adhered
to the Caco-2 cells. It has been reported previously that E. lactis
IITRHR1 can strongly adhere to intestinal epithelial cells, which
promote its survival and show a broad range of antimicrobial
activity (Sharma et al., 2011). Similar to our ﬁndings, these data
demonstrated that the bacterial concentration was reduced by
1.68 log CFU/well, following removal of the non-adhered cells.
Toxicity Assay
Microculture tetrazolium assay was performed to determine
the cytotoxicity eﬀects of the metabolites secreted by E. lactis
IW5 on various cancer cell lines, particularly HeLa, Caco-2,
AGS, and HT-29. The cytotoxicity potential of the metabolites
produced by E. lactis IW5 on various cancer cells was determined
(Figures 1 and 2A–D,F). After 24 h of incubation, the metabolites
inhibited all cancer cell lines. Approximately 38, 36, 28, 40,
and 30% of MCF-7, HeLa, HT-29, AGS, and Caco-2 cells,
respectively, remained viable after these cells were incubated
with the metabolites for 24 h. The antiproliferative eﬀect of
the metabolites on all of the evaluated cancer cells signiﬁcantly
diﬀered from that of the un-treated and reference strain-treated
groups. The eﬀect of the metabolites on FHs 74 normal cells was
also examined (Figure 2E). E. lactis IW5 secretions exhibited no
toxic eﬀect on normal cells; more than 95% of the cells grew well.
These results indicated that E. lactis IW5 is a potential candidate
for cancer treatment.
The anticancer activity of probiotic bacteria has been
demonstrated by in vivo and in vitro systems (Ouwehand,
2007). Probiotic organisms inhibit mammalian cell proliferation
in primary leukocyte cultures and cell lines. The induction of
apoptotic cells by conjugated linoleic acid produced by various
probiotic strains has been established in Caco-2 and HT-29
mammalian cancer cell lines. In this study, four human cancer
cell lines, namely, Caco-2 (colorectal cancer), AGS (gastric
cancer), HeLa (cervical cancer), and HT-29 (colon cancer), and
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TABLE 3 | Real time PCR genes and their forward/reverse primers.
Primer Forward and reverse primer Sequence Amplicon size length
BAX F 5′-CCCGAGAGGTCTTTTTCCGAG-3′ 155 21
R 5′-CCAGCCCATGATGGTTCTGAT-3′ 155 21
BCL2 F 5′-GGTGGGGTCATGTGTGTGG-3′ 130 19
R 5′-CGGTTCAGGTACTCAGTCATCC-3′ 130 22
CASPAS 9 F 5′-CTCAGACCAGAGATTCGCAAAC-3′ 116 22
R 5′-GCATTTCCCCTCAAACTCTCAA-3′ 116 22
CASPAS 8 F 5′-GACAGAGCTTCTTCGAGACAC-3′ 116 21
R 5′-GCTCGGGCATACAGGCAAAT-3′ 116 20
ErbB2 F 5′-TGTGACTGCCTGTCCCTACAA-3′ 152 21
R 5′-CCAGACCATAGCACACTCGG-3′ 152 20
ErbB3 F 5′-GACCCAGGTCTACGATGGGAA-3′ 99 21
R 5′-GTGAGCTGAGTCAAGCGGAG-3′ 99 20
BCL-XL F 5′-GAGCTGGTGGTTGACTTTCTC-3′ 101 21
R 5′-TCCATCTCCGATTCAGTCCCT-3′ 101 21
FIGURE 1 | The cytotoxic effects of isolated Entreococcus lactis IW5 secretion on different cancer cell lines at three time points 12, 24, and 48 h. Error
bars represent the standard deviation of the each mean.
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FIGURE 2 | Effect of E. lactis secretions on the proliferation of cancerous MCF-7, Caco-2, HT-29, HeLa, AGS, and FHs-74 normal cell lines. E. lactis
secretions final concentration: 50 μg/mL, Taxol concentration: IC50 for each cell line. Incubation time is 24 h. Data are expressed as mean and error bars represent
standard deviation of means. UT: Untreated media were used as control. E. lactis IITRHR1 was used as Reference Strain (RS) for comparison. Asterisks denote
statistically significant differences (∗p < 0.05; ∗∗p < 0.01).
one normal cell line, namely, FHs-74, were utilized. The results
of this study demonstrated that the metabolites secreted by
E. lactis IW5 strain signiﬁcantly inhibited the growth of the
four cancer cell lines. E. lactis IW5 secretions decreased the
proliferation and viability of all cancer cell lines but did not
adversely aﬀect FHs-74 normal cells. Therefore, this strain was
considered non-toxic. Diﬀerent cancer cells were treated with
106 CFU/well of E. lactis IW5; this treatment strongly inhibited
the proliferation of cancer cells. In E. lactis IW5 treatment, the
proliferation of MCF-7, HeLa, HT-29, AGS, and Caco-2 cells was
particularly inhibited by 38, 36, 28, 40, and 30%, respectively.
Thus, E. lactis IW5 can inhibit the proliferation of cancer cells;
however, E. lactis IITRHR1could not inhibit the proliferation of
cancer cells.
Apoptosis Assay
HeLa cells were treated with 50 μg/mL of the ﬁltered secretion
after these cells were incubated for 24 h; the treated HeLa
cells were stained with DAPI and analyzed through ﬂuorescent
microscopy to analyze the eﬀect of E. lactis secretions on
HeLa cell viability. The intact viable cells displayed completely
healthy nuclei (Figure 3a); by contrast, the apoptotic cells were
characterized by shrunk cells with condensed (early apoptosis)
or fragmented (late apoptosis) nuclei. Other morphological
and apoptotic changes, such as membrane blebbing and
apoptotic body formation, were observed in the treated cells.
This result suggested that apoptosis is the main cytotoxic
mechanism of bacterial metabolites (Figure 3b).The newly
identiﬁed E. lactis IW5 strain obtained from the human gut
exhibited appropriate probiotic properties, such as high tolerance
to low pH, resistance to high bile salt concentration, and anti-
pathogenic activity against several pathogenic bacteria. Cytotoxic
ﬁndings indicated that E. lactis IW5 secreted metabolites that
possessed high anticancer activity against all of the examined
cancer cell lines (AGS, Caco-2, HeLa, and HT-29). Therefore,
the metabolites produced by E. lactis IW5 strain may be
used as an alternative nutraceutical with promising therapeutic
index because these metabolites are non-cytotoxic to normal
mammalian cells.
Compared with the control cells that exhibited natural cell
death (Figure 3c), the HeLa cells treated with 50 μL/mL of
ﬁltered E. lactis IW5 secretions demonstrated signiﬁcant amounts
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FIGURE 3 | 4′,6-diamidino-2-phenylindole (DAPI) staining and flow cytometric analysis of treated/untreated HeLa cancer cells. (a,b) Untreated and
treated DAPI-stained cells; (c,d) flow cytometric analysis of untreated and treated cells with 50 μg/mL E. lactis secretion metabolites after 24 h incubation. Dots with
Annexin V−/PI+ (Q1), Annexin V+/PI+ (Q2), Annexin V+/PI− (Q3), and Annexin V−/PI− (Q4) and feature represent necrotic, late apoptotic, early apoptotic, and viable
intact cells, respectively.
(p ≤ 0.05) of annexin V+/PI+ (late apoptotic cells) after
incubating for 24 h (Figure 3d). In the treated HeLa cells 87.3 and
6.48% were observed in late apoptosis and necrosis, respectively.
Based on the ﬂow cytometry ﬁndings, E. lactis IW5 secretions can
inhibit the proliferation of cancer cells and the main mechanism
of this prophylactic eﬀect was related to apoptosis induction in
cancer cells.
Quantitative Real Time PCR
As shown in Figure 4, the expression of anti-apoptotic
genes (ERBB 2 and ERBB3), intrinsic apoptosis blocker genes
(BCL-2 and BCL-XL), and CASP 8 gene (starter gene in
TNF-α apoptosis pathway) were signiﬁcantly down-regulated
by E. lactis IW5compared to untreated control group. The
down-regulation in the mentioned genes by E. lactis IW5
was similar to Taxol R© but the expression of CASP 9 (starter
gene in intrinsic apoptosis pathway) and BAX (crucial gene
in extrinsic IL-3 mediated apoptosis pathway) genes was
signiﬁcantly diﬀerent in E. lactis IW5 and Taxol treated
groups (Figure 4). E. lactis IW5 up-regulated the expression
of BAX gene whereas Taxol up-regulated the expression of
CASP9 indicating diﬀerent inducing pathways of apoptosis.
Lactobacillus paracasei M5L can induce apoptosis in HT-
29 cells through reactive oxygen species generation followed
by CRT accompanied endoplasmic reticulum stress and S
phase arrest (Hu et al., 2015). The molecular mechanisms
of pro-apoptotic eﬀects of human-derived Lactobacillus reuteri
ATCC PTA 6475 has been previously investigated on myeloid
leukemia-derived cells and ﬁndings have shown the down-
regulation of nuclear factor-kappaB (NF-kappaB)-dependent
gene products that mediate cell survival (Bcl-2 and Bcl-
xL) related genes (Iyer et al., 2008). Findings of antitumor
eﬀects of cell-bound exopolysaccharides (cb-EPS) isolated from
Lactobacillus acidophilus 606 on HT-29 colon cancer cells
have shown the antitumourigenic eﬀects through the induction
of BAX gene (Kim et al., 2010). In addition, the human
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FIGURE 4 | Apoptosis related gene expression ratio in treated (50 µg/mL E. lactis secretion metabolites) and untreated control HeLa cells for 24 h.
probiotic Propionibacterium freudenreichii could kill HT-29
colorectal adenocarcinoma cells through apoptosis in vitro
via its metabolites (the short chain fatty acids, acetate and
propionate; Lan et al., 2007). Furthermore, the investigation
results of the eﬀect of probiotic Bacillus polyfermenticus on
the growth of human colon cancer cells including HT-29,
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DLD-1, and Caco-2 cells have illustrated that B. polyfermenticus
can inhibit tumor growth and its anticancer activity occurs
through suppressing ErbB2 and ErbB3 genes (Ma et al.,
2010). Based on our ﬁndings, the induction of apoptosis by
E. lactis IW5 is related to extrinsic IL-3 receptor pathway
and it is deferent from Taxol’s apoptosis induction (intrinsic
mitochondria apoptosis pathway).
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